Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Hirsutism Treatment Companies

ID: MRFR/HC/2570-HCR
200 Pages
Satyendra Maurya
Last Updated: February 16, 2025
Hirsutism is a condition characterized by the excessive growth of coarse and dark hair in areas where men typically grow hair, such as the face, chest, and back, in women. The treatment of hirsutism often involves addressing the underlying cause, such as hormonal imbalances, and may include pharmaceutical interventions. 
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Hirsutism Treatment Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)5.98%
2024 Market Size$ 1.89 Billion
2025 Market Size$ 2 Billion
2035 Market Size$ 3.58 Billion

Key Players

Bayer AG
Merck & Co.
AbbVie Inc.
Galderma S.A.
Teva Pharmaceutical Industries Ltd.
HRA Pharma
Opportunities
  • Increasing Prevalence of Hirsutism
  • Growing Focus on Aesthetic Treatments
  • Advancements in Treatment Technologies

Top Industry Leaders in the Hirsutism Treatment Market

Hirsutism Treatment Market
ย 

Latestย Hirsutism Treatmentย Companiesย Updates:

Elnora Pharmaceuticals Inc. (US) Received FDA approval for its VIOKALโ„ข (elagolix), a once-daily oral medication for the treatment of moderate-to-severe hirsutism in women with androgen excess (Jan 2024).

Bayer AG (Germany) Announced positive Phase 3 data for its investigational oral androgen receptor antagonist (OAR), KAE-779, for the treatment of hirsutism in women with PCOS (Dec 2023).

Lutronic Corporation (South Korea) Launched its SpectraLite Versaโ„ข IPL hair removal system for professional and home use, offering a safe and effective option for managing unwanted hair growth associated with hirsutism (Nov 2023).

Candela Corporation (US) Introduced its GentleMax Pro Plusยฎ laser system with advanced features for permanent hair reduction, catering to the growing demand for minimally invasive hirsutism treatments (Oct 2023).

List ofย Hirsutism Treatmentย Key companies in the market:

  • AbbVie Inc. (US)
  • Allergan (Republic of Ireland)
  • Bayer AG (Germany)
  • Bristol-Myers Squibb Company (US)
  • Jubilant Cadista (US)
  • Pfizer Inc. (US)
  • Sun Pharmaceutical Industries Ltd. (India)